Max Rady College of Medicine

Term: Newborn Screening and Public Health Chemistry Section

Printer friendly

Glossary Definition

Last Updated: 2012-12-03

Definition:

Service provider at the Cadham Provincial Laboratory. Responsibilities include Newborn Screening Program and Maternal Serum Screening. The Newborn Screening Program is guided by the Manitoba Perinatal Screening Committee and screens all newborns using a blood test taken between 24 hours and five days after the birth of a baby, used to identify the risk for a number of treatable disorders. The Maternal Serum Screening is completed in collaboration with the Department of Human Genetics of the University of Manitoba: this test is optional to pregnant women during prenatal care and provides an estimation of the risk for fetal open neural tube defects, Down Syndrome, Trisomy 18, and Smith-Lemli-Opitz syndrome. (Government of Manitoba, Cadham Provincial Laboratory - 2011).

Related concepts 

Related terms 

Links 

References 

  • Government of Manitoba, Cadham Provincial Laboratory (2011). Guide to services 2012. Retrieved from: http://www.gov.mb.ca/health/publichealth/cpl/docs/guide.pdf. Accessed July 17, 2012.(View)
  • Government of Manitoba, Cadham Provincial Laboratory. Newborn screening in Manitoba. Retrieved from: http://www.gov.mb.ca/health/publichealth/cpl/baby.html. Accessed May 17, 2012.(View)

Term used in 

  • Lix L, Smith M, Azimaee M, Dahl M, Nicol P, Burchill C, Burland E, Goh C, Schultz J, Bailly A. A Systematic Investigation of Manitoba's Provincial Laboratory Data. Winnipeg, MB: Manitoba Centre for Health Policy, 2012. [Report] [Summary] (View)


Contact us

Manitoba Centre for Health Policy
Community Health Sciences, Max Rady College of Medicine,
Rady Faculty of Health Sciences,
Room 408-727 McDermot Ave.
University of Manitoba
Winnipeg, MB R3E 3P5 Canada

204-789-3819